Pollock, KM; Cheeseman, HM; Szubert, AJ; Libri, V; Boffito, M; Owen, D; Bern, H; ... COVAC1 study Group; + view all Pollock, KM; Cheeseman, HM; Szubert, AJ; Libri, V; Boffito, M; Owen, D; Bern, H; O'Hara, J; McFarlane, LR; Lemm, N-M; McKay, PF; Rampling, T; Yim, YTN; Milinkovic, A; Kingsley, C; Cole, T; Fagerbrink, S; Aban, M; Tanaka, M; Mehdipour, S; Robbins, A; Budd, W; Faust, SN; Hassanin, H; Cosgrove, CA; Winston, A; Fidler, S; Dunn, DT; McCormack, S; Shattock, RJ; COVAC1 study Group; - view fewer (2022) Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial. EClinicalMedicine , 44 , Article 101262. 10.1016/j.eclinm.2021.101262.